secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turn Therapeutics Inc. (TTRX)
CIK:        0002023016
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001104659-25-104028
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Turn Therapeutics enters global supply, development, and license agreement with Medline
--------------------------------------------------------------------------------

- Agreement covers development, manufacture, and commercialization of products using Turn's PermaFusion delivery platform.
- Medline is the largest provider of medical-surgical products and supply chain solutions in the U.S.
- Financial terms, product categories, and development timelines remain confidential per agreement terms.
- CEO Bradley Burnam calls partnership a 'transformative milestone' to accelerate entry into professional and consumer markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023016/000110465925104028/0001104659-25-104028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023016/000110465925104028/tm2529778d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-104028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer